Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.242EUR
−34.80 MEUR
47.54 MEUR
11.86 M
About Centogene N.V.
Sector
CEO
Kim Stratton
Website
Headquarters
Rostock
Employees (FY)
493
Founded
2018
ISIN
NL0014040206
FIGI
BBG00QTPGZB8
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange CENTOGENE NV stocks are traded under the ticker 39K.
Yes, you can track CENTOGENE NV financials in yearly and quarterly reports right on TradingView.
CENTOGENE NV is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
39K net income for the last quarter is −10.85 M EUR, while the quarter before that showed −24.23 M EUR of net income which accounts for 55.20% change. Track more CENTOGENE NV financial stats to get the full picture.
No, 39K doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 22, 2024, the company has 493.00 employees. See our rating of the largest employees — is CENTOGENE NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CENTOGENE NV EBITDA is −32.78 M EUR, and current EBITDA margin is −64.93%. See more stats in CENTOGENE NV financial statements.
Like other stocks, 39K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CENTOGENE NV stock right from TradingView charts — choose your broker and connect to your account.